Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Clinical Research
Monitoring Antigen-specific T Cell Immunity by ELISPOT
By Cellular Technology Limited (CTL). T and B lymphocytes can each generate immune responses to specific antigens. The resulting immunity helps in the prevention of infectious diseases and in rejection of cancer cells.
Monitoring of Cell Mediated Immunity
ELISPOT assays offer unique qualification for cytokine-based immune monitoring and standardization strategies.
Preserving Flexibility in Outsourcing Clinical Services
By Steve Cottrell, inVentiv Clinical Solutions
Beating Cancer
Tumors continue bypassing cell pathways whilst molecular biologists doggedly try to understand how cancer works. Haren Rupani of Novartis explains why we are still in our infancy of cancer knowledge and the importance of imaging in combating the deathly disease.
Late Phase Studies: An Early Priority
Late phase research has sometimes been viewed as less of a priority than the earlier trials required for product registration. By Dipti Amin, Quintiles
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.